Correspondence: John E Thompson, Department of Biology, University of Waterloo, 200 University Avenue West, Waterloo, Ontario, Canada N2L 3G1. E-mail: jet@uwaterloo.ca Received 5 December 2013; Accepted 10 February 2014 Accepted article preview online 26 February 2014; Advance online publication 1 April 2014 The high rates of recurrence and low median survival in many B-cell cancers highlight a need for new targeted therapeutic modalities.
http://ift.tt/1xe5YQM
http://ift.tt/1xe5YQM
No comments:
Post a Comment